
Nabriva Therapeutics plc NBRV
Quarterly report 2023-Q1
added 05-22-2023
Nabriva Therapeutics plc Total Inventories 2011-2026 | NBRV
Annual Total Inventories Nabriva Therapeutics plc
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.68 M | 14.5 M | 5.82 M | 682 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.5 M | 682 K | 7.67 M |
Quarterly Total Inventories Nabriva Therapeutics plc
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.03 M | 9.68 M | 17.3 M | - | 15.6 M | 14.5 M | 15.6 M | 10.1 M | 8.97 M | 5.82 M | 5.82 M | 5.82 M | 5.82 M | 682 K | 682 K | 682 K | 682 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.3 M | 682 K | 7.93 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Verastem
VSTM
|
1.83 M | $ 5.04 | -4.73 % | $ 349 M | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
9.82 M | $ 12.41 | -11.1 % | $ 1.88 B | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
ChemoCentryx
CCXI
|
851 K | - | - | $ 3.74 B | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 317.36 | -3.29 % | $ 41.6 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 19.01 | -2.66 % | $ 889 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 20.75 | -3.35 % | $ 3.44 B | ||
|
Alkermes plc
ALKS
|
197 M | $ 29.39 | -1.77 % | $ 4.84 B | ||
|
AbbVie
ABBV
|
4.95 B | $ 209.4 | -0.81 % | $ 370 B | ||
|
AbCellera Biologics
ABCL
|
6.34 M | $ 3.27 | -2.39 % | $ 977 M | ||
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K |